Capula Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-213,800
Closed -$9.9M – 702
2023
Q2
$9.9M Buy
+213,800
New +$7.39M 0.24% 55

Capula Management's DICE Position: Q3 2023 in Review

Capula Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 213,800 shares — an estimated $9.9M sold.

Capula Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $9.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Capula Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Capula Management sold 213,800 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.9M.
  • Capula Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Capula Management's DICE Therapeutics, Inc. Common Stock position peaked at $9.9M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Capula Management's 13F filing for Q3 2023, filed 3 Nov 2023.